Introduction. Liver transplantation allocation policy has evolved significantly in recent years. Thus, the implementation of new prognostic scores aim to increase equity, reduce deaths and optimize outcomes from the liver transplant waiting list. Material and methods. Between February 2013 and January 2022, we evaluated 265 patients with chronic liver disease, age≥18 years, included on the liver transplant waiting list. UKELD, iMELD, refitMELD, refitMELD-Na, upMELD, MELD 3.0 scores were used. Prognostic abilities for predicting 90-day mortality were investigated by applying receiver-function-characteristic-curb analysis. Results. 39 patients (34%) died of whom (male 28, female 21, mean age 48 years) on the liver transplant waiting list within 90 days of listing. However MELD score 3.0, had the best acceptable prognostic performance with areas below Roccurbe( AUROC = 0.836). All scores achieved an average quality score of 75.1%. In 51.66% of patients, however, there was an increase in the prognostic score than the MELD score. Conclusions. Thus, the MELD 3.0 score effectively predicts shortterm mortality among patients with liver cirrhosis and specifically addresses gender disparities on the liver transplant waiting list while improving posttransplant survival.